Indications for mexiletine in the new ESC guidelines and beyond

Vámos Máté, Zsigmond Előd-János, Hohnloser Stefan H.
2023

Avoiding ICD lead revision in a patient with chronically low R-wave amplitudes

Ernst Matthias, Sághy László, Hohnloser Stefan H., Vámos Máté
2020

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort

Kattih Badder, Operhalski Felix, Boeckling Felicitas, Hecker Florian, Michael Felix, Vámos Máté, Hohnloser Stefan H., Erath Julia W.
2022

Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter Insights from the ATHENA study /

Vámos Máté, Hugh Calkins, Kowey Peter R., Torp-Pedersen Christian T., Genti Valerie Corp Dit, Wieloch Mattias, Koren Andrew, Hohnloser Stefan H.
2020

Dronedarone versus placebo in patients with atrial fibrillation or atrial flutter across a range of renal function a post hoc analysis of the ATHENA trial /

Vámos Máté, Oldgren Jonas, Nam Gi-Byoung, Lip Gregory Y. H., Calkins Hugh, Zhu Jun, Ueng Kwo-Chang, Ludwigs Ulf, Wieloch Mattias, Stewart John, Hohnloser Stefan H.
2022

Age-related regulation and region-specific distribution of ion channel subunits promoting atrial fibrillation in human left and right atria

Biliczki Péter, Boon Reinier A., Girmatsion Zenawit, Bukowska Alicia, Ördög Balázs, Kaess Bernhard M., Hohnloser Stefan H., Goette Andreas, Varró András, Moritz Anton, Nattel Stanley, Ehrlich Joachim R.
2019